Table 1.
Possible sources of measurement heterogeneity in measurements of predictors, illustrated by examples from previously published prediction studies
Type of Predictor | Examples of Predictors | Examples of Measurement Heterogeneity |
---|---|---|
Anthropometric | Height | Guidelines on imaging decisions in osteoporosis care are established using standardized |
measurements | Weight | measurements of height, while in clinical practice height is measured using |
Body circumference | nonstandardized techniques or self‐reported values.8 | |
Physiological | Blood pressure | In scientific studies, blood pressure is often measured by the average of multiple |
measurements | Serum cholesterol | measurements performed under standardized conditions, while blood pressure |
HbA1c | measurements in practice deviate from protocol guidelines in various ways due to | |
Fasting glucose | variability in available time and devices.9 | |
Diagnosis | Previous/current | The diagnosis “hypertension” can be defined as a blood pressure of ≥140/90 mm Hg |
disease | (without use of anti‐hypertensive therapy) or as the use of anti‐hypertensive drugs.10 | |
Treatment/ | Type of drug used | The cut‐off value for an “increased length of stay in the hospital” to predict unplanned |
Exposure status | Smoking status | readmission may depend on the country in which the model is evaluated.11 |
Dietary intake | ||
Imaging | Presence or size of tissue | In scientific studies, review of FDG PET scans may be protocolized or performed by |
on ultrasound, MRI, CT | a single experienced nuclear medicine physician, blinded to patient outcome.12 In routine | |
or FDG PET scans | practice, FDG PET scans may be reviewed under various systematics or by a | |
multidisciplinary team.13 |